Publication - Progress report

New Medicines Reviews 2013

Published: 3 May 2013
Part of:
Health and social care
ISBN:
9781782565604

Reports on the role of SMC & Review of IPTR & ADTC

91 page PDF

324.6 kB

91 page PDF

324.6 kB

Contents
New Medicines Reviews 2013
Appendix 5: NHS board compliance per board for decision-making and timeliness

91 page PDF

324.6 kB

Appendix 5: NHS board compliance per board for decision-making and timeliness

Board Decisions made within 90 days* Decision published on web within 14 days*
NHS A&A 23/23 (100%) 21/23 (91%)
NHS Borders 16/23 (70%) 16/23 (70%)
NHS D&G 22/23 (96%) 16/23 (70%)
NHS Fife 21/23 (91%) 23/23 (100%)
NHS FV 23/23 (100%) 11/23 (48%)
NHS Grampian 13/23 (57%) 19/23 (83%)
NHS GG&C 23/23 (100%) 23/23 (100%)
NHS Highland 18/23 (78%) 12/23 (52%)
NHS Lanarkshire 23/23 (100%) 23/23 (100%)
NHS Lothian 17/23 (74%) 23/23 (100%)
NHS Orkney No Data Provided (as per NHS Grampian)
NHS Shetland No Data Provided (as per NHS Grampian)
NHS Tayside 21/23 (91%) 6/23 (26%)
NHS WI 15/23 (65%) 0/23 (0%) - no data provided
Average % (across 12 boards) 87% 70%
Median % (across 12 boards) 91% 77%

*on 23 medicines audited.


Contact

Email: VERONICA MOFFAT